Show simple item record

dc.contributor.authorMortimore, Gerri
dc.date.accessioned2020-01-30T13:51:58Z
dc.date.available2020-01-30T13:51:58Z
dc.date.issued2020-01
dc.identifier.citationMortimore, G. (2020). 'Primary biliary cholangitis: An update on treatment'. Gastrointestinal disorders: a focus for nurses, pp. 1-2.en_US
dc.identifier.urihttp://hdl.handle.net/10545/624434
dc.description.abstractPrimary biliary cholangitis (PBC), previously known as primary biliary cirrhosis, is a chronic but progressive disease that, over many years, causes damage to bile ducts, leading to cholestasis and, in some patients, cirrhosis. The rate at which PBC progresses varies from person to person, but significant damage takes decades to occur. It predominately affects women aged 40–60 years with a female to male ratio of 9:1, but can affect anyone from the age of 20. There is no cure for PBC other than liver transplant, but medications can be given to slow down disease progression and for the treatment of symptoms. Health professionals should monitor for complications, including the development of osteoporosis, vitamin deficiencies and liver cirrhosis, which caries the associated complications of portal hypertension, varices and ascites.en_US
dc.description.sponsorshipN/Aen_US
dc.language.isoenen_US
dc.publisherMAG Healthcareen_US
dc.relation.urlhttp://hdl.handle.net/10545/624056
dc.subjectprogressive diseaseen_US
dc.subjectcholestasisen_US
dc.subjectPrimary biliary cholangitisen_US
dc.titlePrimary biliary cholangitis: An update on treatmenten_US
dc.typeArticleen_US
dc.contributor.departmentUniversity of Derbyen_US
dc.identifier.journalGastrointestinal disorders: a focus for nursesen_US
dcterms.dateAccepted2019
dc.author.detail782817en_US


This item appears in the following Collection(s)

Show simple item record